Clinical characteristics, target organ damage and associate risk factors of resistant hypertension determined by ambulatory blood pressure monitoring in patients aged ≥ 80 years.

about

Clinical characteristics, target organ damage and associate risk factors of resistant hypertension determined by ambulatory blood pressure monitoring in patients aged ≥ 80 years.

Item

http://www.wikidata.org/entity/Q42209115

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Clinical characteristics, targ ...... g in patients aged ≥ 80 years.

@en

Clinical characteristics, targ ...... g in patients aged ≥ 80 years.

@nl

type

Item

label

Clinical characteristics, targ ...... g in patients aged ≥ 80 years.

@en

Clinical characteristics, targ ...... g in patients aged ≥ 80 years.

@nl

prefLabel

Clinical characteristics, targ ...... g in patients aged ≥ 80 years.

@en

Clinical characteristics, targ ...... g in patients aged ≥ 80 years.

@nl

P1476

Clinical characteristics, targ ...... g in patients aged ≥ 80 years.

@en

P2093

De-Wei Gao

http://www.w3.org/2001/XMLSchema#string

Hua Cui

http://www.w3.org/2001/XMLSchema#string

Jian Cao

http://www.w3.org/2001/XMLSchema#string

Li Fan

http://www.w3.org/2001/XMLSchema#string

Ling-Gen Gao

http://www.w3.org/2001/XMLSchema#string

Zhi-Ru Liang

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.

Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study

Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension

Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008

Incidence and prognosis of resistant hypertension in hypertensive patients.

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion

P304

308-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.11909/J.ISSN.1671-5411.2017.05.015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28630606

http://www.w3.org/2001/XMLSchema#string

P932

5466933

http://www.w3.org/2001/XMLSchema#string